Drugs / Diphtheria-tetanus-acellular pertussis vaccine
Diphtheria-tetanus-acellular pertussis vaccine
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04099303 Comparator | Apr 2020 → Oct 2021 | diphtheria, pertussis, tetanus | CanSino Biologics Inc. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02765126 Comparator | May 2016 → Dec 2019 | — | Clifford Craig Medical Research Trust | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria-tetanus-acellular pertussis vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02765126 ↗ |
| Modality | Vaccine | “Diphtheria-tetanus-acellular pertussis vaccine” NCT02765126 ↗ |
| Route | Intramuscular | “Intramuscular DTaP vaccine” NCT02765126 ↗ |